Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Obesity HELP
Based on 89,430 articles since 2008
|||| 29 

These are the 89430 published articles about Obesity that originated from Worldwide during 2008-2017.
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline 8 USPSTF recommendations FPs need to know about. 2016

Campos-Outcalt, Doug. ·Medical Director, Mercy Care Plan, Phoenix, AZ, USA. Email: campos-outcaltd@mercycareplan.com. ·J Fam Pract · Pubmed #27275937.

ABSTRACT: Treat high blood pressure only if measurements taken outside of the office confirm an initial high BP reading · Screen blood-glucose levels in overweight/obese individuals 40 to 70 years old · and more.

2 Guideline SIO management algorithm for patients with overweight or obesity: consensus statement of the Italian Society for Obesity (SIO). 2016

Santini, Ferruccio / Busetto, Luca / Cresci, Barbara / Sbraccia, Paolo. ·Obesity Center, Endocrinology Unit, University Hospital of Pisa, Pisa, Italy. · Department of Medicine, University of Padua, Padua, Italy. · Section of Diabetology, Careggi University Hospital, Florence, Italy. · Department of Systems Medicine, Medical School, University of Rome Tor Vergata, Via Montpellier 1, 00133, Rome, Italy. sbraccia@med.uniroma2.it. ·Eat Weight Disord · Pubmed #27100225.

ABSTRACT: -- No abstract --

3 Guideline Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). 2016

McClave, Stephen A / Taylor, Beth E / Martindale, Robert G / Warren, Malissa M / Johnson, Debbie R / Braunschweig, Carol / McCarthy, Mary S / Davanos, Evangelia / Rice, Todd W / Cresci, Gail A / Gervasio, Jane M / Sacks, Gordon S / Roberts, Pamela R / Compher, Charlene / Anonymous1540947 / Anonymous1550947. ·Department of Medicine, University of Louisville, Louisville, Kentucky. · Nutrition Support Specialist, Barnes Jewish Hospital, St Louis, Missouri. · Chief Division of General Surgery, Oregon Health and Science University, Portland, Oregon. · Critical Care Dietitian, Portland VA Medical Center, Portland, Oregon. · Clinical Nurse Specialist: Wound, Skin, Ostomy, UW Health University of Wisconsin Hospital and Clinics, Madison, Wisconsin. · Professor, Department of Kinesiology and Nutrition and Division of Epidemiology and Biostatistics, University of Illinois at Chicago, Chicago, Illinois. · Senior Nurse Scientist, Center for Nursing Science and Clinical Inquiry, Madigan Healthcare System, Tacoma, Washington. · Pharmacotherapy Specialist, Nutrition Support, The Brooklyn Hospital Center, Brooklyn, New York. · Assistant Professor of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee. · Project Research Staff, Digestive Disease Institute, Gastroenterology and Pathobiology, Cleveland, Ohio. · Chair and Professor of Pharmacy Practice, Butler University College of Pharmacy and Health Science, Indianapolis, Indiana. · Professor and Head, Department of Pharmacy Practice, Harrison School of Pharmacy, Auburn University, Auburn, Alabama. · Professor and Vice Chair, Division Chief of Critical Care Medicine, Director of Research John A. Moffitt Endowed Chair, Department of Anesthesiology, Oklahoma City, Oklahoma. · Professor of Nutrition Science, University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania compherc@nursing.upenn.edu. · ·JPEN J Parenter Enteral Nutr · Pubmed #26773077.

ABSTRACT: -- No abstract --


Garber, Alan J / Abrahamson, Martin J / Barzilay, Joshua I / Blonde, Lawrence / Bloomgarden, Zachary T / Bush, Michael A / Dagogo-Jack, Samuel / DeFronzo, Ralph A / Einhorn, Daniel / Fonseca, Vivian A / Garber, Jeffrey R / Garvey, W Timothy / Grunberger, George / Handelsman, Yehuda / Henry, Robert R / Hirsch, Irl B / Jellinger, Paul S / McGill, Janet B / Mechanick, Jeffrey I / Rosenblit, Paul D / Umpierrez, Guillermo E / Anonymous3250854 / Anonymous3260854. · ·Endocr Pract · Pubmed #26731084.

ABSTRACT: -- No abstract --

5 Guideline [Current Guidelines to Prevent Obesity in Childhood and Adolescence]. 2016

Blüher, S / Kromeyer-Hauschild, K / Graf, C / Grünewald-Funk, D / Widhalm, K / Korsten-Reck, U / Markert, J / Güssfeld, C / Müller, M J / Moss, A / Wabitsch, M / Wiegand, S. ·IFB AdipositasErkrankungen, Universität Leipzig. · Institut für Humangenetik, Universität Jena. · Institut für Bewegungs- und Neurowissenschaft, Deutsche Sporthochschule Köln. · Training/Coaching, Grünewald-Funk Consulting, Berlin. · Abteiliung für Kinderheilkunde und Jugendmedizin, Universität Wien. · Abteilung für Rehabilitative und Präventive Sportmedizin, Medizinische Universität Freiburg. · Institut für Humanernährung und Lebensmittelkunde, Christian-Albrechts Universität Kiel. · Abteilung für Pädiatrische Endokrinologie und Diabetes, Klinik für Pädiatrie, Universität Ulm. · Abteilung für Pädiatrsiche Endokrinologie und Diabetes, Interdisziplinäre Adipositas-Abteilung, Klinik für Pädiatrie, Universität Ulm. · Abteilung für Pädiatrische Endokrinologie und Diabetes, Charité Universitätsmedizin, Berlin. ·Klin Padiatr · Pubmed #26302179.

ABSTRACT: BACKGROUND: Current guidelines for the prevention of obesity in childhood and adolescence are presented. METHODS: A literature search was performed in Medline via PubMed, and appropriate studies were analysed. RESULTS: Programs to prevent childhood obesity were to date mainly school-based. Effects were limited to date. Analyses tailored to different age groups show that prevention programs have the best effects in younger children (< 12 years). Evidence based recommendations for preschool- and early school age imply the need for interventions addressing parents and teachers alike. During adolescence, school-based interventions were most effective when adolescents were directly addressed. To date, obesity prevention programs have mainly focused on behavior oriented prevention. Recommendations for condition oriented prevention have been suggested by the German Alliance of Non-communicable Diseases and include one hour of physical activity at school, promotion of healthy food choices by taxing unhealthy foods, mandatory quality standards for meals at kindergarten and schools as well as a ban on unhealthy food advertisement addressing children. CONCLUSION: Behavior oriented prevention programs showed hardly any or only limited effects in the long term. Certain risk groups for the development of obesity are not reached effectively by available programs. Due to the heterogeneity of available studies, universally valid conclusions cannot be drawn. The combination with condition oriented prevention, which has to counteract on an obesogenic environment, is crucial for sustainable success of future obesity prevention programs.

6 Guideline An Evidence-based Guide for Obesity Treatment in Primary Care. 2016

Fitzpatrick, Stephanie L / Wischenka, Danielle / Appelhans, Bradley M / Pbert, Lori / Wang, Monica / Wilson, Dawn K / Pagoto, Sherry L / Anonymous6470838. ·Department of Preventive Medicine, Rush University Medical Center, Chicago, Ill. · Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY. · Division of Preventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester. · Department of Community Health Sciences, Boston University School of Public Health, Boston, Mass. · Department of Psychology, University of South Carolina, Columbia. · Division of Preventive and Behavioral Medicine, University of Massachusetts Medical School, Worcester. Electronic address: Sherry.Pagoto@umassmed.edu. · ·Am J Med · Pubmed #26239092.

ABSTRACT: On behalf of the Society of Behavioral Medicine, we present a model of obesity management in primary care based on the 5As counseling framework (Assess, Advise, Agree, Assist, and Arrange). Primary care physicians can use the 5As framework to build and coordinate a multidisciplinary team that: 1) addresses patients' psychosocial issues and medical and psychiatric comorbidities associated with obesity treatment failure; 2) delivers intensive counseling that consists of goal setting, self-monitoring, and problem solving; and 3) connects patients with community resources to assist them in making healthy lifestyle changes. This paper outlines reimbursement guidelines and weight-management counseling strategies, and provides a framework for building a multidisciplinary team to maximize the patient's success at weight management.


Garber, Alan J / Abrahamson, Martin Julian / Barzilay, Joshua I / Blonde, Lawrence / Bloomgarden, Zachary T / Bush, Michael A / Dagogo-Jack, Samuel / Davidson, Michael B / Einhorn, Daniel / Garber, Jeffrey R / Garvey, W Timothy / Grunberger, George / Handelsman, Yehuda / Hirsch, Irl B / Jellinger, Paul S / McGill, Janet B / Mechanick, Jeffrey I / Rosenblit, Paul David / Umpierrez, Guillermo E / Anonymous7140851 / Anonymous7150851. · ·Endocr Pract · Pubmed #26642101.

ABSTRACT: This document represents the official position of the American Association of Clinical Endocrinologists and the American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.

8 Guideline European Guidelines for Obesity Management in Adults. 2015

Yumuk, Volkan / Tsigos, Constantine / Fried, Martin / Schindler, Karin / Busetto, Luca / Micic, Dragan / Toplak, Hermann / Anonymous7060851. ·Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey. · ·Obes Facts · Pubmed #26641646.

ABSTRACT: Obesity is a chronic metabolic disease characterised by an increase of body fat stores. It is a gateway to ill health, and it has become one of the leading causes of disability and death, affecting not only adults but also children and adolescents worldwide. In clinical practice, the body fatness is estimated by BMI, and the accumulation of intra-abdominal fat (marker for higher metabolic and cardiovascular disease risk) can be assessed by waist circumference. Complex interactions between biological, behavioural, social and environmental factors are involved in regulation of energy balance and fat stores. A comprehensive history, physical examination and laboratory assessment relevant to the patient's obesity should be obtained. Appropriate goals of weight management emphasise realistic weight loss to achieve a reduction in health risks and should include promotion of weight loss, maintenance and prevention of weight regain. Management of co-morbidities and improving quality of life of obese patients are also included in treatment aims. Balanced hypocaloric diets result in clinically meaningful weight loss regardless of which macronutrients they emphasise. Aerobic training is the optimal mode of exercise for reducing fat mass while a programme including resistance training is needed for increasing lean mass in middle-aged and overweight/obese individuals. Cognitive behavioural therapy directly addresses behaviours that require change for successful weight loss and weight loss maintenance. Pharmacotherapy can help patients to maintain compliance and ameliorate obesity-related health risks. Surgery is the most effective treatment for morbid obesity in terms of long-term weight loss. A comprehensive obesity management can only be accomplished by a multidisciplinary obesity management team. We conclude that physicians have a responsibility to recognise obesity as a disease and help obese patients with appropriate prevention and treatment. Treatment should be based on good clinical care, and evidence-based interventions; should focus on realistic goals and lifelong multidisciplinary management.

9 Guideline ACOG Practice Bulletin No 156: Obesity in Pregnancy. 2015

Anonymous270975. · ·Obstet Gynecol · Pubmed #26595582.

ABSTRACT: -- No abstract --

10 Guideline Obesity and reproduction: a committee opinion. 2015

Anonymous950845. · ·Fertil Steril · Pubmed #26434804.

ABSTRACT: The purpose of this ASRM Practice Committee report is to provide clinicians with principles and strategies for the evaluation and treatment of couples with infertility associated with obesity. This revised document replaces the Practice Committee document titled, "Obesity and reproduction: an educational bulletin," last published in 2008 (Fertil Steril 2008;90:S21-9).

11 Guideline Danish clinical guidelines for examination and treatment of overweight and obese children and adolescents in a pediatric setting. 2015

Johansen, Anders / Holm, Jens-Christian / Pearson, Seija / Kjærsgaard, Mimi / Larsen, Lone Marie / Højgaard, Birgitte / Cortes, Dina / Anonymous7690832. ·Department of Growth and Reproduction, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark. anders.johansen.01@regionh.dk. · ·Dan Med J · Pubmed #26050836.

ABSTRACT: Overweight children are at an increased risk of becoming obese adults, which may lead to shorter life expectancies in the current generation of children as compared to their parents. Furthermore, being an overweight child has a negative psycho-social impact. We consider obesity in children and adolescents a chronic illness, which is in line with the American Medical Society. We summarize the evidence for the efficacy of a combination of diet, physical activity and behavior-focused interventions in a family-based setting. The present guidelines propose a multidisciplinary service implemented as a "chronic care model" based on "best clinical practice" inspired by an American expert committee and the daily practice of The Children's Obesity Clinic at Copenhagen University Hospital Holbaek. Children and adolescents should be referred for examination and treatment in a pediatric setting when BMI corresponds to an isoBMI of minimum 30 or BMI corresponds to an isoBMI of 25 and complex obesity is suspected. Obtaining a thorough medical history is pivotal. We propose a structured interview to ensure collection of all relevant information. We recommend physical examination focused on BMI, waist circumference, growth, pubertal stage, blood pressure, neurology and skin and provide comprehensive paraclinical investigations for obesity and obesity related conditions. Treatment of obesity in children and adolescents is fully dependent on the combined effort of the entire family. This cannot be overemphasized! The main principle of the treatment is developing an individual detailed plan for every patient to reduce caloric intake whilst increasing physical activity, leaving no ambiguity with the recommendations.

12 Guideline Peri-operative management of the obese surgical patient 2015: Association of Anaesthetists of Great Britain and Ireland Society for Obesity and Bariatric Anaesthesia. 2015

Anonymous8120829 / Nightingale, C E / Margarson, M P / Shearer, E / Redman, J W / Lucas, D N / Cousins, J M / Fox, W T A / Kennedy, N J / Venn, P J / Skues, M / Gabbott, D / Misra, U / Pandit, J J / Popat, M T / Griffiths, R / Anonymous8130829 / Anonymous8140829. · · Society for Obesity and Bariatric Anaesthesia. · Obstetric Anaesthetists' Association. · Royal College of Anaesthetists. · British Association of Day Surgery. · Resuscitation Council (UK). · Association of Anaesthetists of Great Britain & Ireland. · Difficult Airway Society. ·Anaesthesia · Pubmed #25950621.

ABSTRACT: Guidelines are presented for the organisational and clinical peri-operative management of anaesthesia and surgery for patients who are obese, along with a summary of the problems that obesity may cause peri-operatively. The advice presented is based on previously published advice, clinical studies and expert opinion.

13 Guideline Recommendations for growth monitoring, and prevention and management of overweight and obesity in children and youth in primary care. 2015

Anonymous201109 / Parkin, Patricia / Connor Gorber, Sarah / Shaw, Elizabeth / Bell, Neil / Jaramillo, Alejandra / Tonelli, Marcello / Brauer, Paula. · ·CMAJ · Pubmed #25824498.

ABSTRACT: -- No abstract --

14 Guideline Standardized outcomes reporting in metabolic and bariatric surgery. 2015

Brethauer, Stacy A / Kim, Julie / El Chaar, Maher / Papasavas, Pavlos / Eisenberg, Dan / Rogers, Ann / Ballem, Naveen / Kligman, Mark / Kothari, Shanu / Anonymous10825. ·Bariatric and Metabolic Center, Digestive Disease Institute, Cleveland Clinic, 9500 Euclid Ave., M61, Cleveland, OH, 44195, USA, brethas@ccf.org. · ·Obes Surg · Pubmed #25802064.

ABSTRACT: -- No abstract --

15 Guideline The role of endoscopy in the bariatric surgery patient. 2015

Anonymous6120822 / Evans, John A / Muthusamy, V Raman / Acosta, Ruben D / Bruining, David H / Chandrasekhara, Vinay / Chathadi, Krishnavel V / Eloubeidi, Mohamad A / Fanelli, Robert D / Faulx, Ashley L / Fonkalsrud, Lisa / Khashab, Mouen A / Lightdale, Jenifer R / Pasha, Shabana F / Saltzman, John R / Shaukat, Aasma / Wang, Amy / Stefanidis, Dimitrios / Richardson, William S / Kothari, Shanu N / Cash, Brooks D. · ·Gastrointest Endosc · Pubmed #25733126.

ABSTRACT: -- No abstract --

16 Guideline Pharmacological management of obesity: an endocrine Society clinical practice guideline. 2015

Apovian, Caroline M / Aronne, Louis J / Bessesen, Daniel H / McDonnell, Marie E / Murad, M Hassan / Pagotto, Uberto / Ryan, Donna H / Still, Christopher D / Anonymous2470818. ·Boston University School of Medicine and Boston Medical Center (C.M.A.), Boston, Massachusetts 02118; Weill-Cornell Medical College (L.J.A.), New York, New York 10065; Denver Health Medical Center (D.H.B.), Denver, Colorado 80204; Brigham and Women's Hospital (M.E.M.), Boston, Massachusetts 02115; Mayo Clinic, Division of Preventative Medicine (M.H.M.), Rochester, Minnesota 55905; Alma Mater University of Bologna (U.P.), S. Orsola-Malpighi Hospital Endocrinology Unit, 40138 Bologna, Italy; Pennington Biomedical Research Center (D.H.R.), Baton Rouge, Louisiana 70808; and Geisinger Health Care System (C.D.S.), Danville, Pennsylvania 17822. · ·J Clin Endocrinol Metab · Pubmed #25590212.

ABSTRACT: OBJECTIVE: To formulate clinical practice guidelines for the pharmacological management of obesity. PARTICIPANTS: An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. This guideline was co-sponsored by the European Society of Endocrinology and The Obesity Society. EVIDENCE: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe the strength of recommendations and the quality of evidence. CONSENSUS PROCESS: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, the European Society of Endocrinology, and The Obesity Society reviewed and commented on preliminary drafts of these guidelines. Two systematic reviews were conducted to summarize some of the supporting evidence. CONCLUSIONS: Weight loss is a pathway to health improvement for patients with obesity-associated risk factors and comorbidities. Medications approved for chronic weight management can be useful adjuncts to lifestyle change for patients who have been unsuccessful with diet and exercise alone. Many medications commonly prescribed for diabetes, depression, and other chronic diseases have weight effects, either to promote weight gain or produce weight loss. Knowledgeable prescribing of medications, choosing whenever possible those with favorable weight profiles, can aid in the prevention and management of obesity and thus improve health.

17 Guideline (5) Prevention or delay of type 2 diabetes. 2015

Anonymous4330816. · ·Diabetes Care · Pubmed #25537704.

ABSTRACT: -- No abstract --

18 Guideline [Dyslipidemia management in children and adolescents: recommendations of the Nutrition Branch of the Chilean Society of Pediatrics]. 2014

Barja Y, Salesa / Cordero B, María Luisa / Baeza L, Cecilia / Hodgson B, María Isabel / Anonymous6250821. · ·Rev Chil Pediatr · Pubmed #25697255.

ABSTRACT: The prevalence of dyslipidemia has dramatically increased in children and adolescents, and many of these cases are associated with increased obesity. As this condition represents cardiovascular risk in the future, the bases of its treatment should be widely known. In the vast majority of patients, there will be lifestyle changes, specific diet and increased physical activity, usually all of these resulting in a favorable response. Only a minority will require drug treatment, which must be prescribed by a specialist in the context of a comprehensive cardiovascular risk assessment, including the patient and his family. The prevention of cardiovascular risk factors should be performed by all members of the health team. This article presents the recommendations of the Nutrition specialists of the Chilean Society of Pediatrics for screening, diagnosis and treatment of dyslipidemia in childhood.

19 Guideline Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance. 2014

Stegenga, Heather / Haines, Alexander / Jones, Katie / Wilding, John / Anonymous1490813. ·National Collaborating Centre for Mental Health, Royal College of Psychiatrists, London, UK. · National Clinical Guideline Centre, Royal College of Physicians of London, London NW1 4LE, UK Alexander.Haines@rcplondon.ac.uk. · National Clinical Guideline Centre, Royal College of Physicians of London, London NW1 4LE, UK. · University of Liverpool and University Hospital Aintree, Liverpool, UK. · ·BMJ · Pubmed #25430558.

ABSTRACT: -- No abstract --

20 Guideline Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of eating disorders. 2014

Hay, Phillipa / Chinn, David / Forbes, David / Madden, Sloane / Newton, Richard / Sugenor, Lois / Touyz, Stephen / Ward, Warren / Anonymous4890810. ·Members of the CPG Working Group School of Medicine and Centre for Health Research, University of Western Sydney, Australia School of Medicine, James Cook University, Townsville, Australia p.hay@uws.edu.au. · Members of the CPG Working Group Capital and Coast District Health Board, Wellington, New Zealand. · Members of the CPG Working Group School of Pediatrics and Child Health, University of Western Australia, Perth, Australia. · Members of the CPG Working Group Eating Disorders Service, Sydney Children's Hospital Network, Westmead, Australia; School of Psychiatry, University of Sydney, Australia. · Members of the CPG Working Group Mental Health CSU, Austin Health, Australia; University of Melbourne, Australia. · Members of the CPG Working Group Department of Psychological Medicine, University of Otago at Christchurch, New Zealand. · Members of the CPG Working Group School of Psychology and Centre for Eating and Dieting Disorders, University of Sydney, Australia. · Members of the CPG Working Group Eating Disorders Service Royal Brisbane and Women's Hospital; University of Queensland, Brisbane, Australia. · ·Aust N Z J Psychiatry · Pubmed #25351912.

ABSTRACT: OBJECTIVES: This clinical practice guideline for treatment of DSM-5 feeding and eating disorders was conducted as part of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) Clinical Practice Guidelines (CPG) Project 2013-2014. METHODS: The CPG was developed in accordance with best practice according to the National Health and Medical Research Council of Australia. Literature of evidence for treatments of anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), other specified and unspecified eating disorders and avoidant restrictive food intake disorder (ARFID) was sourced from the previous RANZCP CPG reviews (dated to 2009) and updated with a systematic review (dated 2008-2013). A multidisciplinary working group wrote the draft CPG, which then underwent expert, community and stakeholder consultation, during which process additional evidence was identified. RESULTS: In AN the CPG recommends treatment as an outpatient or day patient in most instances (i.e. in the least restrictive environment), with hospital admission for those at risk of medical and/or psychological compromise. A multi-axial and collaborative approach is recommended, including consideration of nutritional, medical and psychological aspects, the use of family based therapies in younger people and specialist therapist-led manualised based psychological therapies in all age groups and that include longer-term follow-up. A harm minimisation approach is recommended in chronic AN. In BN and BED the CPG recommends an individual psychological therapy for which the best evidence is for therapist-led cognitive behavioural therapy (CBT). There is also a role for CBT adapted for internet delivery, or CBT in a non-specialist guided self-help form. Medications that may be helpful either as an adjunctive or alternative treatment option include an antidepressant, topiramate, or orlistat (the last for people with comorbid obesity). No specific treatment is recommended for ARFID as there are no trials to guide practice. CONCLUSIONS: Specific evidence based psychological and pharmacological treatments are recommended for most eating disorders but more trials are needed for specific therapies in AN, and research is urgently needed for all aspects of ARFID assessment and management. EXPERT REVIEWERS: Associate Professor Susan Byrne, Dr Angelica Claudino, Dr Anthea Fursland, Associate Professor Jennifer Gaudiani, Dr Susan Hart, Ms Gabriella Heruc, Associate Professor Michael Kohn, Dr Rick Kausman, Dr Sarah Maguire, Ms Peta Marks, Professor Janet Treasure and Mr Andrew Wallis.

21 Guideline Guidelines for laparoscopic peritoneal dialysis access surgery. 2014

Haggerty, Stephen / Roth, Scott / Walsh, Danielle / Stefanidis, Dimitrios / Price, Raymond / Fanelli, Robert D / Penner, Todd / Richardson, William / Anonymous210809. ·Division of General Surgery, NorthShore University Healthsystem, Evanston, IL, USA, shaggerty@northshore.org. · ·Surg Endosc · Pubmed #25294537.

ABSTRACT: -- No abstract --

22 Guideline [Interdisciplinary European guidelines on metabolic and bariatric surgery]. 2014

Fried, M / Yumuk, V / Oppert, J M / Scopinaro, N / Torres, A / Weiner, R / Yashkov, Y / Frühbeck, G. · ·Rozhl Chir · Pubmed #25263472.

ABSTRACT: In 2012, an outstanding expert panel derived from IFSO-EC (International Federation for the Surgery of Obesity - European Chapter) and EASO (European Association for the Study of Obesity), composed by key representatives of both Societies including past and present presidents together with EASOs OMTF (Obesity Management Task Force) chair, agreed to devote the joint Medico-Surgical Workshop of both institutions to the topic of metabolic surgery as a pre-satellite of the 2013 European Congress on Obesity (ECO) to be held in Liverpool given the extraordinarily advancement made specifically in this field during the past years. It was further agreed to revise and update the 2008 Interdisciplinary European Guidelines on Surgery of Severe Obesity produced in cooperation of both Societies by focusing in particular on the evidence gathered in relation to the effects on diabetes during this lustrum and the subsequent changes that have taken place in patient eligibility criteria. The expert panel composition allowed the coverage of key disciplines in the comprehensive management of obesity and obesity-associated diseases, aimed specifically at updating the clinical guidelines to reflect current knowledge, expertise and evidence-based data on metabolic and bariatric surgery.

23 Guideline Nonsurgical management of urinary incontinence in women: a clinical practice guideline from the American College of Physicians. 2014

Qaseem, Amir / Dallas, Paul / Forciea, Mary Ann / Starkey, Melissa / Denberg, Thomas D / Shekelle, Paul / Anonymous330960. · ·Ann Intern Med · Pubmed #25222388.

ABSTRACT: DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the nonsurgical management of urinary incontinence (UI) in women. METHODS: This guideline is based on published English-language literature on nonsurgical management of UI in women from 1990 through December 2013 that was identified using MEDLINE, the Cochrane Library, Scirus, and Google Scholar. The outcomes evaluated for this guideline include continence, improvement in UI, quality of life, adverse effects, and discontinuation due to adverse effects. It grades the evidence and recommendations by using ACP's guideline grading system. The target audience is all clinicians, and the target patient population is all women with UI. RECOMMENDATION 1: ACP recommends first-line treatment with pelvic floor muscle training in women with stress UI. (Grade: strong recommendation, high-quality evidence). RECOMMENDATION 2: ACP recommends bladder training in women with urgency UI. (Grade: strong recommendation, moderate-quality evidence). RECOMMENDATION 3: ACP recommends pelvic floor muscle training with bladder training in women with mixed UI. (Grade: strong recommendation, moderate-quality evidence). RECOMMENDATION 4: ACP recommends against treatment with systemic pharmacologic therapy for stress UI. (Grade: strong recommendation, low-quality evidence). RECOMMENDATION 5: ACP recommends pharmacologic treatment in women with urgency UI if bladder training was unsuccessful. Clinicians should base the choice of pharmacologic agents on tolerability, adverse effect profile, ease of use, and cost of medication. (Grade: strong recommendation, high-quality evidence). RECOMMENDATION 6: ACP recommends weight loss and exercise for obese women with UI. (Grade: strong recommendation, moderate-quality evidence).

24 Guideline [Consensus document for the detection and management of chronic kidney disease]. 2014

Martínez-Castelao, Alberto / Górriz, José L / Bover, Jordi / Segura-de la Morena, Julián / Cebollada, Jesús / Escalada, Javier / Esmatjes, Enric / Fácila, Lorenzo / Gamarra, Javier / Gràcia, Silvia / Hernández-Moreno, Julio / Llisterri-Caro, José L / Mazón, Pilar / Montañés, Rosario / Morales-Olivas, Francisco / Muñoz-Torres, Manuel / de Pablos-Velasco, Pedro / de Santiago, Ana / Sánchez-Celaya, Marta / Suárez, Carmen / Tranche, Salvador. ·Sociedad Española de Nefrología (SEN), Barcelona, España. Electronic address: amartinez@bellvitgehospital.cat. · Sociedad Española de Nefrología (SEN), Barcelona, España. · Sociedad Española de Hipertensión Arterial-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA), Madrid, España. · Sociedad Española de Medicina Interna (SEMI), Madrid, España. · Sociedad Española de Endocrinología y Nutrición (SEEN), Madrid, España. · Sociedad Española de Diabetes (SED), Madrid, España. · Sociedad Española de Cardiología (SEC), Madrid, España. · Sociedad Española de Médicos Generalistas (AP) (SEMG), Madrid, España. · Sociedad Española de Química Clínica (SEQC), Madrid, España. · Sociedad Española de Medicina Rural y Generalista (AP) (SEMERGEN), Madrid, España. · Sociedad Española de Medicina de Familia y Comunitaria (AP) (SEMFyC), Madrid, España. ·Endocrinol Nutr · Pubmed #25171835.

ABSTRACT: Chronic kidney disease (CKD) is an important global health problem, involving to 10% of the Spanish population, promoting high morbidity and mortality for the patient and an elevate consumption of the total health resources for the National Health System. This is a summary of an executive consensus document of ten scientific societies involved in the care of the renal patient, that actualizes the consensus document published in 2007. The central extended document can be consulted in the web page of each society. The aspects included in the document are: Concept, epidemiology and risk factors for CKD. Diagnostic criteria, evaluation and stages of CKD, albuminuria and glomerular filtration rate estimation. Progression factors for renal damage. Patient remission criteria. Follow-up and objectives of each speciality control. Nephrotoxicity prevention. Cardio-vascular damage detection. Diet, life-style and treatment attitudes: hypertension, dyslipidaemia, hyperglycemia, smoking, obesity, hyperuricemia, anemia, mineral and bone disorders. Multidisciplinary management for Primary Care, other specialities and Nephrology. Integrated management of CKD patient in haemodialysis, peritoneal dialysis and renal transplant patients. Management of the uremic patient in palliative care. We hope that this document may be of help for the multidisciplinary management of CKD patients by summarizing the most updated recommendations.

25 Guideline Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: U.S. Preventive Services Task Force Recommendation Statement. 2014

LeFevre, Michael L / Anonymous4800804. · ·Ann Intern Med · Pubmed #25155419.

ABSTRACT: DESCRIPTION: Update and refinement of the 2003 U.S. Preventive Services Task Force (USPSTF) recommendation on dietary counseling for adults with risk factors for cardiovascular disease (CVD). METHODS: The USPSTF reviewed the evidence on whether primary care-relevant counseling interventions for a healthful diet and physical activity modify self-reported behaviors, intermediate physiologic outcomes, diabetes incidence, and cardiovascular morbidity or mortality in adults with CVD risk factors, as well as the adverse effects of counseling interventions. POPULATION: This recommendation applies to adults aged 18 years or older in primary care settings who are overweight or obese and have known CVD risk factors (hypertension, dyslipidemia, impaired fasting glucose, or the metabolic syndrome). RECOMMENDATION: The USPSTF recommends offering or referring adults who are overweight or obese and have additional CVD risk factors to intensive behavioral counseling interventions to promote a healthful diet and physical activity for CVD prevention. (B recommendation).